WODC USA A look at our US delegation

…and the US is represented…!

In Market Access, Orphan Drug Congress, Orphan Drugs Live by Freya Smale

We are thrilled to announce the US payers that are participating at this year’s World Orphan Drug Congress USA 2016!

Download the brochure to find out more about the event >

John Coster, Director, Division of Pharmacy, Center for Medicare and Medicaid Services (CMS) will be providing insight into US national medicaid coverage and payment policy for orphan drugs

  • CMS National Medicaid Program – prescription drug benefit overview
  • State Medicaid Program Requirements
    • Drug coverage and payment
      • Prior Authorization Requirements (if any)
    • Payment methodologies (current and future)
  • Manufacturer requirements – Medicaid Drug Rebate Program enrollment and Rebate payment requirements; NDA, BLA and ANDA Approvals

Medicaid state overview from Jeff Myers, President & CEO, Medicaid Health Plans of America

  • Drug utilization review
  • Establishing clinical step edits and prior authoriztion criteria
  • Supplemental rebates for “preferred” position

And Ed Pezalla, Vice President, National Medical Director for Pharmaceutical Policy and Strategy, Aetna will be providing the Private payer perspective. 

Register before January 29th and save 20% on your delegate pass >*

World Orphan Drug Congress USA 2016

*Please note that access to this sessions is limited to those who purchase a 3 day or a 2.5 day ticket.